A detailed history of Bsw Wealth Partners transactions in Chroma Dex Corp. stock. As of the latest transaction made, Bsw Wealth Partners holds 93,847 shares of CDXC stock, worth $551,820. This represents 0.07% of its overall portfolio holdings.

Number of Shares
93,847
Previous 88,847 5.63%
Holding current value
$551,820
Previous $324,000 53.7%
% of portfolio
0.07%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$3.25 - $7.72 $16,250 - $38,600
5,000 Added 5.63%
93,847 $498,000
Q3 2024

Oct 29, 2024

BUY
$2.51 - $3.8 $223,005 - $337,618
88,847 New
88,847 $324,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $402M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.